Annal Oncol:CXCR4示胰腺癌远处转移

2012-03-03 MedSci MedSci原创

 CXCR4与胰腺癌远处转移具有独立的强相关性,SMAD4阴性表达可能将被用于预测辅助化疗效果。该研究结果由法国学者2月29日在线发表于《肿瘤学年鉴》(Annals of Oncology)。   该研究共纳入了471例已接受手术切除治疗的胰腺癌患者,采用组织微阵列法评估了SMAD4、TGF-βⅡ型受体、CXCR4和LKB1的表达,并分析其与患者总生存状况的关联。   结果

 CXCR4与胰腺癌远处转移具有独立的强相关性,SMAD4阴性表达可能将被用于预测辅助化疗效果。该研究结果由法国学者2月29日在线发表于《肿瘤学年鉴》(Annals of Oncology)。

  该研究共纳入了471例已接受手术切除治疗的胰腺癌患者,采用组织微阵列法评估了SMAD4、TGF-βⅡ型受体、CXCR4和LKB1的表达,并分析其与患者总生存状况的关联。

  结果发现,CXCR4高表达是唯一与不良预后有独立相关性的生物标志物[危险比(HR)=1.74,P<0.0001],此外,它还与远处转移显著相关(HR=0.29,P<0.0001)。在未接受辅助治疗的患者中,SMAD4阴性表达趋于与总生存率降低相关。再者,SMAD4阴性表达与复发类型无关,但对辅助化疗效果具有预测作用。

  相关链接:Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864338, encodeId=7fc2186433828, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Feb 14 14:45:00 CST 2013, time=2013-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412445, encodeId=f7cc1412445b3, content=<a href='/topic/show?id=c5d95546ff' target=_blank style='color:#2F92EE;'>#CXCR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5546, encryptionId=c5d95546ff, topicName=CXCR4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c832868137, createdName=chenwq09, createdTime=Mon Mar 05 01:45:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423485, encodeId=2f96142348555, content=<a href='/topic/show?id=badd9441868' target=_blank style='color:#2F92EE;'>#远处转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94418, encryptionId=badd9441868, topicName=远处转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42b3793913, createdName=hanhaisha2009, createdTime=Mon Mar 05 01:45:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
    2013-02-14 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864338, encodeId=7fc2186433828, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Feb 14 14:45:00 CST 2013, time=2013-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412445, encodeId=f7cc1412445b3, content=<a href='/topic/show?id=c5d95546ff' target=_blank style='color:#2F92EE;'>#CXCR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5546, encryptionId=c5d95546ff, topicName=CXCR4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c832868137, createdName=chenwq09, createdTime=Mon Mar 05 01:45:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423485, encodeId=2f96142348555, content=<a href='/topic/show?id=badd9441868' target=_blank style='color:#2F92EE;'>#远处转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94418, encryptionId=badd9441868, topicName=远处转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42b3793913, createdName=hanhaisha2009, createdTime=Mon Mar 05 01:45:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
    2012-03-05 chenwq09
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864338, encodeId=7fc2186433828, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Feb 14 14:45:00 CST 2013, time=2013-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412445, encodeId=f7cc1412445b3, content=<a href='/topic/show?id=c5d95546ff' target=_blank style='color:#2F92EE;'>#CXCR4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5546, encryptionId=c5d95546ff, topicName=CXCR4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c832868137, createdName=chenwq09, createdTime=Mon Mar 05 01:45:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423485, encodeId=2f96142348555, content=<a href='/topic/show?id=badd9441868' target=_blank style='color:#2F92EE;'>#远处转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94418, encryptionId=badd9441868, topicName=远处转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42b3793913, createdName=hanhaisha2009, createdTime=Mon Mar 05 01:45:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]